Note to the businessman

Found results: 345

Note to the businessman

Rebuilding at Glaxo

One of the areas of restructuring of the pharmaceutical giant GlaxoSmithKline is the division of the early research department into 40 research groups, in fact, small biotech firms.

04.02.2011
Note to the businessman

It's time for a change in biotechnology

PwC Report "Restructuring of the Biotechnology Industry": in order to survive, companies must actively develop cooperation to develop a new business model focused on innovation and success.

29.11.2010
Note to the businessman

Profit-based philanthropy

"I don't want to be called either a venture investor or a business angel," says Chikunov. — These are all American terms. I call myself the helper of those who want to help humanity. Maybe I'm a philanthropist?"

01.11.2010
Note to the businessman

Russian venture capitalist from Palo Alto

Venture capitalists are interested in markets with good development potential. "Now is the time to think about Russia," says Evgeny Zaitsev, a member of the American delegation at the Global Innovation Partnership Forum, one of the partners of the Helix Ventures venture fund.

18.10.2010
Note to the businessman

Conditions for innovation will improve by an imaginary amount

Experts are not inclined to overestimate the initiative of the department: "Any step in this direction can only be welcomed – Russia lags far behind other countries in the field of innovation... But this step is tiny."

02.09.2010
Note to the businessman

You are attractive for investment...

Due to the fact that the main purpose of investment activity is to ensure the most effective forms of capital investment, each business entity should pay special attention to its investment attractiveness.

30.08.2010
Note to the businessman

The price of innovation

In the vast majority of developed businesses, there is no need to put the issue of pricing at the forefront, since the market itself is able to adjust prices. The approach to pricing innovative products looks somewhat more complicated.

25.08.2010
Note to the businessman

Neudorf invites investors

The purpose of the creation of the special economic zone "Neudorf" is to boost innovative development and commercialization of scientific achievements in instrumentation, information technology and pharmaceuticals. On the territory of the SEZ, all conditions have been created for investors to work.

21.07.2010
Note to the businessman

Personalized medicine and genomics at the International Economic Forum

The achievements of genomics will make medicine more personalized in the near future, but there are both scientific and economic obstacles on this path, according to the participants of the panel session "What's after the genome?", which took place on Friday as part of the St. Petersburg International Economic Forum.

21.06.2010
Note to the businessman

I will buy shares of JSC "Rusnano"

The State Duma adopted in the first reading a bill on the reorganization of the Russian Nanotechnology Corporation (Rusnano) into an open joint stock company.

04.06.2010